Exploring genetic factors in neuropathic pain
Official title: Exploring the Genetics of Neuropathic Pain
Run by Oslo University Hospital · NCT03862365 · Data updated 2026-11-12
This study is trying to find out if certain genes are linked to neuropathic pain to help understand why some people experience this condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 5 sites (Bergen and 4 other locations) |
| Status | Recruiting |
| Started | August 1, 2018 |
| Main results expected | January 1, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | November 7, 2023 |
| Trial ID | NCT03862365 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 18 to 70 who have been referred for evaluation of possible distal symmetric polyneuropathy.
✕Probably not a fit
Patients who are too sick to participate or have conditions such as dementia or acute inflammatory polyneuropathy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify new genetic variants associated with the development of neuropathic pain, a condition affecting 7-8% of the general population. By utilizing existing population-based cohorts and establishing a registry and biobank for patients with neuropathy, the researchers will conduct genetic association studies to uncover molecular mechanisms underlying neuropathic pain. The study will involve international collaboration to ensure a large and diverse patient population, enhancing the reliability of the findings.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients suffering from neuropathic pain.
How similar studies have gone: Previous genetic studies on rare neuropathic disorders have shown promise in identifying mechanisms of neuropathic pain, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The patient is between 18 and 70 years old. 2. The patient has consented. 3. The patient is referred for evaluation of possible distal symmetric polyneuropathy (DSPN). 4. The patient has filled out the questionnaires. Exclusion Criteria: 1. The patient is too sick to participate (eg. bedridden, fever). 2. The patient is unable to consent (eg. dementia, speech problems, psychiatric disorder). 3. Inflammatory acute polyneuropathy.
Where it's running
-
Haukeland University Hospital
Bergen, Norway Recruiting -
Oslo University Hospital
Oslo, Norway Recruiting -
Helse Stavanger HF
Stavanger, Norway Recruiting -
University Hospital of North Norway
Tromsø, Norway Recruiting -
St. Olavs Hospital
Trondheim, Norway Recruiting
Study contacts
- Principal investigator: David Benett, M.D. — University of Oxford
- Study coordinator: Kristian B. Nilsen, M.D
- Email: uxnikq@ous-hf.no
- Phone: +4791372241
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Advancing genomic medicine using electronic health records
This study is trying to see if using electronic health records and helpful reminders can get more patients tested for genetic conditions in a way that doctors can easily use.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Extended-release Pregabalin for nerve pain from diabetes or shingles
This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.
-
High-Intensity Peripheral Magnetic Stimulation for Traumatic Nerve Injury
This study tests whether adding high-intensity peripheral magnetic stimulation to a structured exercise program can reduce pain and improve function for adults with a traumatic peripheral nerve injury.
-
Hematological clues and how patients respond to nerve blocks for neuropathic pain
This study looks at blood inflammation markers to see if they relate to how well people with neuropathic pain respond to sympathetic nerve blocks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.